Cite
Co-delivery of IKBKE siRNA and cabazitaxel by hybrid nanocomplex inhibits invasiveness and growth of triple-negative breast cancer.
MLA
Zhen Zhao, et al. “Co-Delivery of IKBKE SiRNA and Cabazitaxel by Hybrid Nanocomplex Inhibits Invasiveness and Growth of Triple-Negative Breast Cancer.” Science Advances, vol. 6, no. 29, July 2020, pp. 1–14. EBSCOhost, https://doi.org/10.1126/sciadv.abb0616.
APA
Zhen Zhao, Yuanke Li, Hao Liu, Jain, A., Patel, P. V., & Kun Cheng. (2020). Co-delivery of IKBKE siRNA and cabazitaxel by hybrid nanocomplex inhibits invasiveness and growth of triple-negative breast cancer. Science Advances, 6(29), 1–14. https://doi.org/10.1126/sciadv.abb0616
Chicago
Zhen Zhao, Yuanke Li, Hao Liu, Akshay Jain, Pratikkumar Vinodchandra Patel, and Kun Cheng. 2020. “Co-Delivery of IKBKE SiRNA and Cabazitaxel by Hybrid Nanocomplex Inhibits Invasiveness and Growth of Triple-Negative Breast Cancer.” Science Advances 6 (29): 1–14. doi:10.1126/sciadv.abb0616.